Knockdown of Akt sensitizes osteosarcoma cells to apoptosis induced by cisplatin treatment

32Citations
Citations of this article
19Readers
Mendeley users who have this article in their library.

Abstract

Akt plays an important role in the inhibition of apoptosis induced by chemotherapy and other stimuli. We therefore investigated if knockdown of Akt2 promoted drug-induced apoptosis in cultured osteosarcoma cells in vitro. SAOS-2 cells were transfected with Akt2 siRNA. The sensitivity of the transformed cell line to the chemotherapeutic drug cisplatin was assessed. Reduced expression of Akt2 did not directly inhibit the growth rate of the transfected cells; however, it significantly increased their sensitivity to cisplatin. Knockdown of Akt2, together with cisplatin treatment, promoted the expression of p53 up-regulated modulator of apoptosis (PUMA). It is possible that the augmentation of cisplatin cytotoxicity may be mediated by PUMA activation. The results of this study suggest that knockdown of Akt2 expression may have therapeutic applications in enhancing the efficacy of chemotherapy in patients with osteosarcoma. © 2011 by the authors.

Cite

CITATION STYLE

APA

Zhang, G., Li, M., Zhu, X., Bai, Y., & Yang, C. (2011). Knockdown of Akt sensitizes osteosarcoma cells to apoptosis induced by cisplatin treatment. International Journal of Molecular Sciences, 12(5), 2994–3005. https://doi.org/10.3390/ijms12052994

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free